These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 459052)

  • 1. Lilly to provide consumer leaflet on Darvon.
    Elliott J
    JAMA; 1979 Aug 24-31; 242(8):702-3. PubMed ID: 459052
    [No Abstract]   [Full Text] [Related]  

  • 2. Darvon manufacturer distributes consumer leaflet.
    W V Med J; 1979 Oct; 75(10):xviii. PubMed ID: 294713
    [No Abstract]   [Full Text] [Related]  

  • 3. Consumer group urges Food and Drug Administration to ban drug Darvon.
    Willens JS
    Pain Manag Nurs; 2006 Jun; 7(2):43. PubMed ID: 16730316
    [No Abstract]   [Full Text] [Related]  

  • 4. In brief: propoxyphene toxicity.
    Med Lett Drugs Ther; 2010 Sep; 52(1346):69. PubMed ID: 20814401
    [No Abstract]   [Full Text] [Related]  

  • 5. New warning on propoxyphene.
    FDA Drug Bull; 1979 Sep; 9(4):22-3. PubMed ID: 488581
    [No Abstract]   [Full Text] [Related]  

  • 6. Darvon safety.
    Pettinga CW
    Science; 1979 Apr; 204(4388):6. PubMed ID: 432625
    [No Abstract]   [Full Text] [Related]  

  • 7. Propoxyphene.
    Am Fam Physician; 1979 May; 19(5):69-70. PubMed ID: 443170
    [No Abstract]   [Full Text] [Related]  

  • 8. Washington Report. Carter's purge: the Califano file.
    Greenberg DS
    N Engl J Med; 1979 Aug; 301(8):451-2. PubMed ID: 460362
    [No Abstract]   [Full Text] [Related]  

  • 9. Darvon removed from the market.
    Willens JS
    Pain Manag Nurs; 2011 Mar; 12(1):1. PubMed ID: 21349443
    [No Abstract]   [Full Text] [Related]  

  • 10. Darvon is still in the public eye.
    Willens JS
    Pain Manag Nurs; 2010 Mar; 11(1):1. PubMed ID: 20207322
    [No Abstract]   [Full Text] [Related]  

  • 11. An FDA overview of nutritional guidelines and nutritional labeling.
    Schaffner RM
    IMJ Ill Med J; 1972 Sep; 142(3):205-7. PubMed ID: 4403960
    [No Abstract]   [Full Text] [Related]  

  • 12. Federal government faces painful decision on Darvon.
    Smith RJ
    Science; 1979 Mar; 203(4383):857-8. PubMed ID: 419410
    [No Abstract]   [Full Text] [Related]  

  • 13. The patient medication instruction (PMI) leaflet: regulatory and evidentiary ramifications.
    Yacura M
    Spec Law Dig Health Care (Mon); 1986 Mar; 8(1):7-27. PubMed ID: 10276993
    [No Abstract]   [Full Text] [Related]  

  • 14. The Food and Drug Administration's import alerts appear to be "misbranded".
    Humphrey CM
    Food Drug Law J; 2003; 58(4):595-612. PubMed ID: 15027452
    [No Abstract]   [Full Text] [Related]  

  • 15. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homeopathic drugs: look-alike meds.
    Consum Rep; 2008 Jun; 73(6):45. PubMed ID: 18979665
    [No Abstract]   [Full Text] [Related]  

  • 17. US consumer group criticizes proposal to allow drug makers to challenge safety information.
    McCarthy M
    BMJ; 2015 Mar; 350():h1514. PubMed ID: 25784706
    [No Abstract]   [Full Text] [Related]  

  • 18. The issue of extralabel drug use.
    Kennedy JA
    J Am Vet Med Assoc; 1997 Dec; 211(11):1354. PubMed ID: 9394877
    [No Abstract]   [Full Text] [Related]  

  • 19. Off-label drugs: question your doctor.
    Consum Rep; 2007 Jun; 72(6):47. PubMed ID: 17632948
    [No Abstract]   [Full Text] [Related]  

  • 20. Rx with a dose of info.
    Miller RW
    FDA Consum; 1980 Nov; 14(9):22-3. PubMed ID: 10309292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.